Who invested in HuidaGene Therapeutics?
HuidaGene Therapeutics's investors include Hill House Capital, Mayo Clinic and Sherpa Healthcare Partners.
Who invested in HuidaGene Therapeutics
Funding summaryUpdated 26 Oct 2026
Undisclosedraised across 1 round since 2022, from 1 source
- Latest round
- VentureMay 2022
- Investors
- 3
The rounds
- May 2022
Everyone who backed them
Sherpa Healthcare PartnersVC firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about HuidaGene Therapeutics
How much has HuidaGene Therapeutics raised?
HuidaGene Therapeutics has raised 1 round since 2022, none with a disclosed amount.
When did HuidaGene Therapeutics last raise?
HuidaGene Therapeutics's most recent round was a Venture in May 2022.
Who backed HuidaGene Therapeutics first?
HuidaGene Therapeutics's first round on record, in May 2022, was backed by Hill House Capital, Mayo Clinic and Sherpa Healthcare Partners.
What stage is HuidaGene Therapeutics at?
HuidaGene Therapeutics's latest named round is a Venture, in May 2022.
Companies like HuidaGene Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.